Dow Up 0.11% Nasdaq Up 0.50%

Clovis Oncology, Inc. (CLVS)

-NasdaqGS
47.56 Down 0.19(0.40%) Aug 29, 4:00PM EDT
|After Hours : 47.57 Up 0.01 (0.01%) Aug 29, 4:45PM EDT
Prev Close:47.75
Open:47.68
Bid:47.01 x 100
Ask:50.98 x 100
1y Target Est:81.11
Beta:2.19
Earnings Date:Oct 29 - Nov 3 (Est.)
Day's Range:47.02 - 48.75
52wk Range:35.33 - 93.33
Volume:388,847
Avg Vol (3m):832,098
Market Cap:1.62B
P/E (ttm):N/A
EPS (ttm):-3.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CLVS

Comparison

Symbol% ChgMkt Cap
CLVSDown 0.40%1.62B
IMMUUp 4.06%310.07M
LRUSF 0.00%57.96M
THLDUp 1.96%246.96M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):119.03
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-4.06
Quarterly EPS Est (Sep-14) :-1.07
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback